
Sign up to save your podcasts
Or
Lou Niles joins Being Patient Live Talks to discuss his experience taking part in the donanemab clinical trial. The monoclonal antibody drug was revealed to have promising results in late 2023 and is currently awaiting FDA approval.
4.6
99 ratings
Lou Niles joins Being Patient Live Talks to discuss his experience taking part in the donanemab clinical trial. The monoclonal antibody drug was revealed to have promising results in late 2023 and is currently awaiting FDA approval.
7,211 Listeners
1,318 Listeners
12,758 Listeners
710 Listeners
2,051 Listeners
1,674 Listeners
4,899 Listeners
3,546 Listeners
9,290 Listeners
8,150 Listeners
143 Listeners
8,203 Listeners
2,067 Listeners
20,143 Listeners
17 Listeners